NCT00835952View on ClinicalTrials.gov

ATX-101 Abdominoplasty

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions
Characteristics of Subcutaneous Fat
Interventions
DRUG

ATX-101

ATX-101 single doses

Trial Locations (2)

Unknown

San Francisco

Santa Monica

Sponsors
All Listed Sponsors
lead

Kythera Biopharmaceuticals

INDUSTRY